The RANKL-OPG system in clinical periodontology

Journal of Clinical Periodontology

Volumn 39, Issue 3, 2012, Pages 239-248

  Belibasakis, Georgios N ^a,b   Bostanci, Nagihan ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

diagnostics; gingival crevicular fluid; osteoprotegerin; periodontal disease; receptor activator of NF B ligand; receptor activator of NF B ligand osteoprotegerin ratio

Indexed keywords

BIOLOGICAL MARKER; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ALVEOLAR BONE LOSS; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS; GINGIVA; GINGIVITIS; HUMAN; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; OSTEOBLAST; OSTEOPOROSIS; PERIODONTAL LIGAMENT; PERIODONTITIS; REVIEW; SALIVA; SMOKING; TOOTH PLAQUE;

ALVEOLAR BONE LOSS; ANIMALS; BIOLOGICAL MARKERS; DENTAL PLAQUE; DIABETES MELLITUS; GINGIVA; GINGIVAL CREVICULAR FLUID; HUMANS; LYMPHOCYTES; OSTEOBLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; PERIODONTITIS; RANK LIGAND; SALIVA; SMOKING;

EID: 84856591543     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2011.01810.x     Document Type: Review

References (79)

1. Allam, E., Draz, A., Hassan, A., Neamat, A., Galal, M., &, Windsor, L. J., (2010) Expression of receptor activator of nuclear factor kappaB ligand in ligature-induced periodontitis in osteoporotic and non-osteoporotic rats. Journal of Periodontal Research 45, 136-142.
2. Belibasakis, G. N., Bostanci, N., Hashim, A., Johansson, A., Aduse-Opoku, J., Curtis, M. A., &, Hughes, F. J., (2007) Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. Microbial Pathogenesis 43, 46-53. (Pubitemid 46678646)
3. Belibasakis, G. N., Emingil, G., Saygan, B., Turkoglu, O., Atilla, G., &, Bostanci, N., (2011a) Gene expression of transcription factor NFATc1 in periodontal diseases. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 119, 167-172.
4. Belibasakis, G. N., Meier, A., Guggenheim, B., &, Bostanci, N., (2011b) The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. Cytokine 55, 98-103.
5. Belibasakis, G. N., Reddi, D., &, Bostanci, N., (2011c) Porphyromonas gingivalis Induces RANKL in T-cells. Inflammation 34, 133-138.
6. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., &, Cerretti, D. P., (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733. (Pubitemid 27098094)
7. Bostanci, N., Emingil, G., Afacan, B., Han, B., Ilgenli, T., Atilla, G., Hughes, F. J., &, Belibasakis, G. N., (2008) Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases. Journal of Dental Research 87, 273-277.
8. Bostanci, N., Ilgenli, T., Emingil, G., Afacan, B., Han, B., Toz, H., Atilla, G., Hughes, F. J., &, Belibasakis, G. N., (2007a) Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. Journal of Clinical Periodontology 34, 370-376.
9. Bostanci, N., Ilgenli, T., Emingil, G., Afacan, B., Han, B., Toz, H., Berdeli, A., Atilla, G., McKay, I. J., Hughes, F. J., &, Belibasakis, G. N., (2007b) Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. Journal of Periodontal Research 42, 287-293.
10. Bostanci, N., Saygan, B., Emingil, G., Atilla, G., &, Belibasakis, G. N., (2011) Effect of periodontal treatment on receptor activator of NF-kappaB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. Journal of Clinical Periodontology 38, 428-433.
11. Buduneli, N., Biyikoglu, B., Sherrabeh, S., &, Lappin, D. F., (2008) Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. Journal of Clinical Periodontology 35, 846-852.
12. Buduneli, N., Buduneli, E., &, Kutukculer, N., (2009) Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. Journal of Periodontology 80, 1274-1280.
13. Buduneli, N., &, Kinane, D. F., (2011) Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. Journal of Clinical Periodontology 38 (Suppl. 11), 85-105.
14. Cesar-Neto, J. B., Duarte, P. M., de Oliveira, M. C., Tambeli, C. H., Sallum, E. A., &, Nociti, F. H. Jr, (2007) Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues. Journal of Periodontal Research 42, 184-191.
15. Crotti, T., Smith, M. D., Hirsch, R., Soukoulis, S., Weedon, H., Capone, M., Ahern, M. J., &, Haynes, D., (2003) Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Journal of Periodontal Research 38, 380-387. (Pubitemid 37465544)
16. Dereka, X. E., Markopoulou, C. E., Fanourakis, G., Tseleni-Balafouta, S., &, Vrotsos, I. A., (2010) RANKL and OPG mRNA level after non-surgical periodontal treatment. Inflammation 33, 200-206.
17. Duarte, P. M., Szeremeske de Miranda, T., Lima, J. A., Dias Goncalves, T. E., Santos, V. R., Bastos, M. F., &, Ribeiro, F. V., (2011) Expression of immune-inflammatory markers in sites of chronic periodontitis in type 2 diabetic subjects. Journal of Periodontology doi: 10.1902/jop.2011.110324.
18. Dutzan, N., Gamonal, J., Silva, A., Sanz, M., &, Vernal, R., (2009) Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. Journal of Clinical Periodontology 36, 396-403.
19. El-Sharkawy, H., Aboelsaad, N., Eliwa, M., Darweesh, M., Alshahat, M., Kantarci, A., Hasturk, H., &, Van Dyke, T. E., (2010) Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. Journal of Periodontology 81, 1635-1643.
20. Ernst, C. W., Lee, J. E., Nakanishi, T., Karimbux, N. Y., Rezende, T. M., Stashenko, P., Seki, M., Taubman, M. A., &, Kawai, T., (2007) Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease. Clinical and Experimental Immunology 148, 271-280. (Pubitemid 46587581)
21. Frodge, B. D., Ebersole, J. L., Kryscio, R. J., Thomas, M. V., &, Miller, C. S., (2008) Bone remodeling biomarkers of periodontal disease in saliva. Journal of Periodontology 79, 1913-1919.
22. Garlet, G. P., Martins, W. Jr, Fonseca, B. A., Ferreira, B. R., &, Silva, J. S., (2004) Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. Journal of Clinical Periodontology 31, 671-679. (Pubitemid 39092231)
23. Garlet, T. P., Coelho, U., Repeke, C. E., Silva, J. S., Cunha Fde, Q., &, Garlet, G. P., (2008) Differential expression of osteoblast and osteoclast chemmoatractants in compression and tension sides during orthodontic movement. Cytokine 42, 330-335.
24. Garlet, T. P., Coelho, U., Silva, J. S., &, Garlet, G. P., (2007) Cytokine expression pattern in compression and tension sides of the periodontal ligament during orthodontic tooth movement in humans. European Journal of Oral Sciences 115, 355-362.
25. Haffajee, A. D., Socransky, S. S., &, Goodson, J. M., (1983) Comparison of different data analyses for detecting changes in attachment level. Journal of Clinical Periodontology 10, 298-310.
26. Han, X., Kawai, T., Eastcott, J. W., &, Taubman, M. A., (2006) Bacterial-responsive B lymphocytes induce periodontal bone resorption. Journal of Immunology 176, 625-631. (Pubitemid 43023311)
27. Han, X., Lin, X., Seliger, A. R., Eastcott, J., Kawai, T., &, Taubman, M. A., (2009) Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. Oral Microbiology and Immunology 24, 190-196.
28. Honda, T., Domon, H., Okui, T., Kajita, K., Amanuma, R., &, Yamazaki, K., (2006) Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clinical and Experimental Immunology 144, 35-40.
29. Ikeda, T., Kasai, M., Suzuki, J., Kuroyama, H., Seki, S., Utsuyama, M., &, Hirokawa, K., (2003) Multimerization of the receptor activator of nuclear factor-kappaB ligand (RANKL) isoforms and regulation of osteoclastogenesis. The Journal of Biological Chemistry 278, 47217-47222. (Pubitemid 37452308)
30. Ikeda, T., Kasai, M., Utsuyama, M., &, Hirokawa, K., (2001) Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus. Endocrinology 142, 1419-1426. (Pubitemid 32299669)
31. Jabbar, S., Drury, J., Fordham, J., Datta, H. K., Francis, R. M., &, Tuck, S. P., (2011) Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. Journal of Periodontal Research 46, 97-104.
32. Jin, Q., Cirelli, J. A., Park, C. H., Sugai, J. V., Taba, M. Jr, Kostenuik, P. J., &, Giannobile, W. V., (2007) RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Journal of Periodontology 78, 1300-1308.
33. Johnson, G. K., &, Guthmiller, J. M., (2007) The impact of cigarette smoking on periodontal disease and treatment. Periodontology 44, 178-194.
34. Jung, K., Lein, M., Hosslin, K., Grosse, A., Roth, S., Possinger, K., &, Luftner, D., (2002) Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. International Journal of Biological Markers 17, 177-181. (Pubitemid 35370061)
35. Kajiya, M., Giro, G., Taubman, M. A., Han, X., Mayer, M. P., &, Kawai, T., (2010) Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. Journal of Oral Microbiology 2, doi: 10.3402/jom.v2i0.5532.
36. Kanzaki, H., Chiba, M., Shimizu, Y., &, Mitani, H., (2001) Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. Journal of Dental Research 80, 887-891. (Pubitemid 32477422)
37. Kawai, T., Matsuyama, T., Hosokawa, Y., Makihira, S., Seki, M., Karimbux, N. Y., Goncalves, R. B., Valverde, P., Dibart, S., Li, Y. P., Miranda, L. A., Ernst, C. W., Izumi, Y., &, Taubman, M. A., (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 169, 987-998. (Pubitemid 44411961)
38. Kinane, D. F., Preshaw, P. M., &, Loos, B. G., (2011) Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions-consensus of the Seventh European Workshop on Periodontology. Journal of Clinical Periodontology 38 (Suppl. 11), 44-48.
39. Kobayashi-Sakamoto, M., Hirose, K., Isogai, E., &, Chiba, I., (2004) NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells. Biochemical and Biophysical Research Communications 315, 107-112. (Pubitemid 38175192)
40. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., &, Penninger, J. M., (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
41. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., &, Boyle, W. J., (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176. (Pubitemid 28180851)
42. Lamster, I. B., &, Ahlo, J. K., (2007) Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Annals of the New York Academy of Sciences 1098, 216-229. (Pubitemid 47092548)
43. Lamster, I. B., Lalla, E., Borgnakke, W. S., &, Taylor, G. W., (2008) The relationship between oral health and diabetes mellitus. Journal of the American Dental Association 139 (Suppl.), 19S-24S.
44. Lappin, D. F., Eapen, B., Robertson, D., Young, J., &, Hodge, P. J., (2009) Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. Journal of Clinical Periodontology 36, 634-641.
45. Lappin, D. F., Sherrabeh, S., Jenkins, W. M., &, Macpherson, L. M., (2007) Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. Journal of Clinical Periodontology 34, 271-277.
46. Lee, J. H., Choi, Y. J., Heo, S. H., Lee, J. M., &, Cho, J. Y., (2011) Tumor necrosis factor-alpha converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. BMB Reports 44, 473-477.
47. Lerner, U. H., (2004) New Molecules In The Tumor Necrosis Factor Ligand And Receptor Superfamilies With Importance For Physiological And Pathological Bone Resorption. Critical Reviews in Oral Biology and Medicine 15, 64-81.
48. Lerner, U. H., (2006) Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. Journal of Dental Research 85, 596-607. (Pubitemid 44085948)
49. Lin, X., Han, X., Kawai, T., &, Taubman, M. A., (2011) Antibody to receptor activator of NF-kappaB ligand ameliorates T cell-mediated periodontal bone resorption. Infection and Immunity 79, 911-917.
50. Liu, D., Xu, J. K., Figliomeni, L., Huang, L., Pavlos, N. J., Rogers, M., Tan, A., Price, P., &, Zheng, M. H., (2003) Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. International Journal of Molecular Medicine 11, 17-21.
51. Liu, Y. C., Lerner, U. H., &, Teng, Y. T., (2010) Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 52, 163-206.
52. Lu, H. K., Chen, Y. L., Chang, H. C., Li, C. L., &, Kuo, M. Y., (2006) Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Journal of Periodontal Research 41, 354-360. (Pubitemid 44392308)
53. Lum, L., Wong, B. R., Josien, R., Becherer, J. D., Erdjument-Bromage, H., Schlondorff, J., Tempst, P., Choi, Y., &, Blobel, C. P., (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. The Journal of Biological Chemistry 274, 13613-13618.
54. Mogi, M., &, Otogoto, J., (2007) Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis. Archives of Oral Biology 52, 894-898. (Pubitemid 47125834)
55. Mogi, M., Otogoto, J., Ota, N., &, Togari, A., (2004) Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. Journal of Dental Research 83, 166-169. (Pubitemid 41713803)
56. Ozcaka, O., Nalbantsoy, A., Kose, T., &, Buduneli, N., (2010) Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. Australian Dental Journal 55, 405-410.
57. Ribeiro, F. V., de Mendon, A. A., Santos, V. R., Bastos, M. F., Figueiredo, L. C., &, Duarte, P. M., (2011) Cytokines and bone-related factors in systemically-healthy and type 2 diabetic subjects with chronic periodontitis. Journal of Periodontology 82, 1187-1196.
58. Sakata, M., Shiba, H., Komatsuzawa, H., Fujita, T., Ohta, K., Sugai, M., Suginaka, H., &, Kurihara, H., (1999) Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. Journal of Bone and Mineral Research 14, 1486-1492. (Pubitemid 29416674)
59. Sakellari, D., Menti, S., &, Konstantinidis, A., (2008) Free soluble receptor activator of nuclear factor-kappab ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. Journal of Clinical Periodontology 35, 938-943.
60. Santos, V. R., Lima, J. A., Goncalves, T. E., Bastos, M. F., Figueiredo, L. C., Shibli, J. A., &, Duarte, P. M., (2010) Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. Journal of Periodontology 81, 1455-1465.
61. Silva, N., Dutzan, N., Hernandez, M., Dezerega, A., Rivera, O., Aguillon, J. C., Aravena, O., Lastres, P., Pozo, P., Vernal, R., &, Gamonal, J., (2008) Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. Journal of Clinical Periodontology 35, 206-214.
62. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., &, Boyle, W. J., (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319. (Pubitemid 27199902)
63. Suzuki, J., Ikeda, T., Kuroyama, H., Seki, S., Kasai, M., Utsuyama, M., Tatsumi, M., Uematsu, H., &, Hirokawa, K., (2004) Regulation of osteoclastogenesis by three human RANKL isoforms expressed in NIH3T3 cells. Biochemical and Biophysical Research Communications 314, 1021-1027. (Pubitemid 38142386)
64. Takayanagi, H., (2007) The role of NFAT in osteoclast formation. Annals of the New York Academy of Sciences 1116, 227-237. (Pubitemid 350274348)
65. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T., &, Taniguchi, T., (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell 3, 889-901. (Pubitemid 35460788)
66. Tang, T. H., Fitzsimmons, T. R., &, Bartold, P. M., (2009) Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid. Journal of Clinical Periodontology 36, 713-718.
67. Taubman, M. A., &, Kawai, T., (2001) Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12, 125-135. (Pubitemid 32429279)
68. Taubman, M. A., Kawai, T., &, Han, X., (2007) The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. Journal of Clinical Periodontology 34, 367-369.
69. Teitelbaum, S. L., (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
70. Teitelbaum, S. L., &, Ross, F. P., (2003) Genetic regulation of osteoclast development and function. Nature Reviews Genetics 4, 638-649. (Pubitemid 36917505)
71. Teng, Y. T., (2002) Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)- mediated alveolar bone destruction in vivo. Infection and Immunity 70, 5269-5273.
72. Teng, Y. T., Nguyen, H., Gao, X., Kong, Y. Y., Gorczynski, R. M., Singh, B., Ellen, R. P., &, Penninger, J. M., (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. Journal of Clinical Investigation 106, R59-67.
73. Uitto, V. J., (2003) Gingival crevice fluid-an introduction. Periodontology 31, 9-11.
74. Valverde, P., Kawai, T., &, Taubman, M. A., (2004) Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. Journal of Bone and Mineral Research 19, 155-164. (Pubitemid 41295148)
75. Vega, D., Maalouf, N. M., &, Sakhaee, K., (2007) CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. Journal of Clinical Endocrinology and Metabolism 92, 4514-4521. (Pubitemid 350223419)
76. Vernal, R., Chaparro, A., Graumann, R., Puente, J., Valenzuela, M. A., &, Gamonal, J., (2004) Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. Journal of Periodontology 75, 1586-1591. (Pubitemid 40260007)
77. Vernal, R., Dutzan, N., Hernandez, M., Chandia, S., Puente, J., Leon, R., Garcia, L., Del Valle, I., Silva, A., &, Gamonal, J., (2006) High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4 + T lymphocytes. Journal of Periodontology 77, 1772-1780. (Pubitemid 44680243)
78. Wara-aswapati, N., Surarit, R., Chayasadom, A., Boch, J. A., &, Pitiphat, W., (2007) RANKL upregulation associated with periodontitis and Porphyromonas gingivalis. Journal of Periodontology 78, 1062-1069.
79. Wise, G. E., Lumpkin, S. J., Huang, H., &, Zhang, Q., (2000) Osteoprotegerin and osteoclast differentiation factor in tooth eruption. Journal of Dental Research 79, 1937-1942. (Pubitemid 32489338)